DADC
ARCT icon

D.A. Davidson & Co’s Arcturus Therapeutics ARCT Stock Holding History

D.A. Davidson & Co’s Portfolio ARCT Stock Details ARCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-143
Closed -$4K – 2379
2016
Q2 		$4K Buy
+143
New +$4.51K ﹤0.01% 2151

Other funds holding ARCT

Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
VMI
VHCP Management II New York $379M AUM 421.62% 1-Year Est. Return
KCM
Knoll Capital Management Miami, Florida $214M AUM 62.74% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return
VM
VHCP Management New York $93M AUM 10.04% 1-Year Est. Return
GTC
Ghost Tree Capital New York $331M AUM 70.11% 1-Year Est. Return
KCM
Kingdon Capital Management New York $976M AUM 66.76% 1-Year Est. Return

D.A. Davidson & Co's ARCT Position: Q3 2016 in Review

D.A. Davidson & Co sold out of Arcturus Therapeutics (ARCT) in Q3 2016, closing a stake of 143 shares — an estimated $4K sold.

D.A. Davidson & Co first reported a position in ARCT in Q2 2016 and held it in 1 quarter. The position peaked at $4K in Q2 2016. 43 funds tracked by Wall St. Rank hold ARCT as of Q3 2016.

  • D.A. Davidson & Co reported no remaining Arcturus Therapeutics position as of Q3 2016 after selling out during the quarter.
  • D.A. Davidson & Co sold 143 Arcturus Therapeutics shares in Q3 2016, an estimated $4K.
  • D.A. Davidson & Co first reported a position in Arcturus Therapeutics in Q2 2016 and held it in 1 quarter.
  • D.A. Davidson & Co's Arcturus Therapeutics position peaked at $4K in Q2 2016.
  • 43 funds tracked by Wall St. Rank held Arcturus Therapeutics as of Q3 2016.

Based on D.A. Davidson & Co's 13F filing for Q3 2016, filed 14 Nov 2016.